• OPEN AN ACCOUNT
Indian Indices
Sensex
77,611.37 -43.23
( -0.06%)
Global Indices
Nasdaq
51,626.09 -1,142.23
(-2.16%)
Dow Jones
7,338.46 -111.32
(-1.49%)
Hang Seng
61,899.63 465.44
(0.76%)
Nikkei 225
10,896.96 25.94
(0.24%)
Forex
USD-INR
95.71 -0.26
(-0.27%)
EUR-INR
108.89 -0.40
(-0.37%)
GBP-INR
127.22 -0.62
(-0.49%)
JPY-INR
0.58 0.00
(-0.38%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.9559391
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
143.8
95420.14
EPS(TTM)
Face Value()
Div & Yield %
7.95
1
0.7
 

Kati patang Lifestyle reports consolidated net loss of Rs 3.71 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Kati patang Lifestyle reported to Rs 3.71 crore in the quarter ended March 2026 as against net loss of Rs 1.66 crore during the previous quarter ended March 2025. Sales rose 21.28% to Rs 2.28 crore in the quarter ended March 2026 as against Rs 1.88 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 9.51 crore in the year ended March 2026 as against net loss of Rs 3.20 crore during the previous year ended March 2025. Sales declined 18.86% to Rs 8.86 crore in the year ended March 2026 as against Rs 10.92 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.281.88 21 8.8610.92 -19
OPM %-168.86-143.62 --105.19-52.11 -
PBDT-3.66-2.25 -63 -9.27-4.79 -94
PBT-3.70-2.25 -64 -9.41-4.93 -91
NP-3.71-1.66 -123 -9.51-3.20 -197